,date,symbol,fillingDate,acceptedDate,period,netIncome,depreciationAndAmortization,deferredIncomeTax,stockBasedCompensation,changeInWorkingCapital,accountsReceivables,inventory,accountsPayables,otherWorkingCapital,otherNonCashItems,netCashProvidedByOperatingActivities,investmentsInPropertyPlantAndEquipment,acquisitionsNet,purchasesOfInvestments,salesMaturitiesOfInvestments,otherInvestingActivites,netCashUsedForInvestingActivites,debtRepayment,commonStockIssued,commonStockRepurchased,dividendsPaid,otherFinancingActivites,netCashUsedProvidedByFinancingActivities,effectOfForexChangesOnCash,netChangeInCash,cashAtEndOfPeriod,cashAtBeginningOfPeriod,operatingCashFlow,capitalExpenditure,freeCashFlow,link,finalLink
0,2019-12-31,GUD.TO,2019-12-31,2019-12-31,FY,18033000,4270000.0,913000.0,2137000.0,-12199000,-10403000,8146000.0,10680000,-18242000,381000.0,4596000.0,0.0,0.0,-247262000,418463000,-11506000,0.0,-8612000.0,0.0,-54413000,0.0,0.0,0.0,6502000.0,0.0,174268000,244785000,4596000.0,-2948000.0,1648000.0,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer
0,2018-12-31,GUD.TO,2018-12-31,2018-12-31,FY,24079000,1932000.0,1850000.0,2170000.0,-23338000,-2580000.0,88000.0,1075000.0,-23340000,-98000.0,-5739000.0,0.0,0.0,-558570000,271103000,35737000,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-4147000.0,0.0,244785000,496460000,-5739000.0,-3872000.0,-9611000.0,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer
0,2017-12-31,GUD.TO,2017-12-31,2017-12-31,FY,17244000,1629000.0,2058000.0,3038000.0,3050000.0,-3201000.0,-434000.0,1818000.0,-964000.0,-6268000.0,23457000,0.0,0.0,-335672000,267150000,18723000,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3689000.0,0.0,496460000,514942000,23457000,-126000.0,23331000,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer
0,2016-12-31,GUD.TO,2016-12-31,2016-12-31,FY,18560000,437000.0,723000.0,3640000.0,-3462000.0,-3446000.0,670000.0,1943000.0,195000.0,-6996000.0,14738000,0.0,0.0,-552188000,549422000,-31950000,0.0,0.0,313679000,-350000.0,0.0,0.0,0.0,1451000.0,0.0,514942000,237481000,14738000,-9860000.0,4878000.0,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer
0,2015-12-31,GUD.TO,2015-12-31,2015-12-31,FY,34167000,124000.0,910000.0,4421000.0,-3818000.0,-1970000.0,-858000.0,326000.0,-624000.0,-7712000.0,7636000.0,0.0,0.0,-610279000,543007000,140000.0,0.0,0.0,12501000,0.0,0.0,-207000.0,0.0,-2068000.0,0.0,237481000,283445000,7636000.0,-1750000.0,5886000.0,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer
0,2014-12-31,GUD.TO,2014-12-31,2014-12-31,FY,125858872,85189.0,772120.0,1804898.0,4510390.0,-740545.0,-601780.0,1643881.0,0.0,-725529.0,803343.0,0.0,0.0,-149807993,169880.0,-38941363,0.0,-2500000.0,83066243,-595000.0,0.0,1000000.0,0.0,-2410213.0,0.0,283445451,1.0,803343.0,-69683.0,733660.0,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer
